$1.5M sweet spot round size
Most of their 109 investments are in rounds between $30M and $73M
2006
CG Oncology raised $105M on August 2, 2023
Investors: Decheng Capital, Avidity Partners, TCG X, Foresite Capital, RA Capital Management, L.P., Malin Corporation plc and Longitude Capital
CG Oncology raised $105M on August 2, 2023
Investors: Decheng Capital, Foresite Capital, Malin Corporation plc, TCG X, Avidity Partners, RA Capital Management, L.P. and Longitude Capital
Quanta Therapeutics raised $51M on May 22, 2023
Investors: Sofinnova Ventures, Russia technology fund, Avidity Partners, Vida Ventures, LLC, Surveyor Capital and Longitude Capital
Cortica raised $75M on April 17, 2023
Investors: Questa Capital Management, ECHO, Ajax Health, Optum Ventures, Aperture Venture Partners, .406 Ventures, RA Capital Management, L.P., Autism Impact Fund and Longitude Capital
NOCD raised $34M on January 31, 2023
Investors: Cigna Ventures, Health Enterprise Partners, 7wire Ventures, F-Prime Capital Partners and Longitude Capital
Alpha-9 Theranostics Inc. raised $75M on December 14, 2022
Investors: Nextech Invest, Samsara BioCapital, Quark Venture and Longitude Capital
Opna Bio raised $38M on November 21, 2022
Investors: Northpond Ventures, Menlo Ventures and Longitude Capital
CG Oncology raised $120M on November 15, 2022
Investors: RA Capital Management, L.P., Acorn Bioventures, ORI Capital Limited, Sirona Capital, Decheng Capital and Longitude Capital
Zenas BioPharma raised $118M on November 7, 2022
Investors: Tellus BioVentures, -, Xencor, Vivo Capital, Quan Capital 泉创资本, Perceptive Advisors, Wellington Management and Longitude Capital
Rivus Pharmaceuticals raised $132M on September 22, 2022
Investors: RA Capital Management, L.P., Medicxi and Longitude Capital